Skip to main content

Cerevel Therapeutics Holdings, Inc.

CEREDelisted Aug 1, 2024
Industry
Pharmaceutical Preparations
SEC CIK
0001805387

Cerevel Therapeutics Holdings, Inc. was delisted on Aug 1, 2024; its insiders filed their last Form 4 on Aug 5, 2024; 231 institutions reported holding it in 13F filings for Q2 2024, worth $6.42B in total; Soros Fund Management was the only superinvestor holding it.

Q1 2023 vs. Q4 2022

How the institutions holding Cerevel Therapeutics Holdings, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of CERE: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders125119−6
Shares134.0M135.4M+1.41M (+1.1%)
Value$4.23B$3.30B−$924.2M (−21.9%)

New holders (15)

Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to CERE in Q1 2023
InstitutionSharesValue% of portfolio
Paradigm Biocapital Advisors LP1,595,199$38.9M3.69%
Millennium Management LLC464,990$11.3M0.01%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.420,793$10.3M0.04%
Balyasny Asset Management LLC349,602$8.53M0.03%
Eventide Asset Management, LLC312,000$7.61M0.14%
Boone Capital Management LLC300,000$7.32M3.43%
Soleus Capital Management, L.P.155,000$3.78M0.47%
Weiss Multi-Strategy Advisers LLC78,703$1.92M0.05%
Profund Advisors LLC39,316$958.9K0.06%
Ergoteles LLC17,405$424.5K0.02%
Simplex Trading, LLC9,848$240.0K0.01%
Wolverine Trading, LLC8,982$215.0K0.01%
Dark Forest Capital Management LP3,093$75.4K0.02%
Cutler Group LP1,200$29.0K0.00%
Ronald Blue Trust, Inc.7$00.00%

Sold out (21)

Institutions that held Cerevel Therapeutics Holdings, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.